
Optical coherence tomography may have a role in providing an honest assessment of visual potential for patients who have undergone surgery for visual loss due to compression.

Optical coherence tomography may have a role in providing an honest assessment of visual potential for patients who have undergone surgery for visual loss due to compression.

Results of a study using optical coherence tomography to evaluate macular changes after cataract surgery indicate that laser refractive lens surgery with a proprietary femtosecond laser system is associated with less macular thickening and volume increase compared with traditional phacoemulsification.

The author takes on the critics of good ol' Rnnald McDonald.

The phacoemulsification performed equally well in a comparative study that also considered the different incision sizes.

Although the rate of glaucoma progression varies widely between patients, and prognostic factors to identify patients at higher risk for faster progression have been identified, the answer to the question of whether there are certain subgroups of patients who should be treated more aggressively than others is "no."

Descemet's membrane detachment and posterior wound gape, when they occur, develop very early after cataract surgery and decrease thereafter, while the incidence of posterior wound retraction emerges more slowly but is present in most eyes by 3 years postoperatively.

In patients with progressive optic nerve sheath meningiomas, fractionated stereotactic radiotherapy is the standard of care and prevents further vision loss.

The answer to the question of whether it is necessary to diagnose and treat pre-perimetric glaucoma is not a simple "yes" or "no."

The addition of intraoperative aberrometry to proper preoperative measurements and available clinical history improves refractive and functional outcomes after cataract surgery with accomudating IOL implantation in postLASIK patients.

The use of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration has revolutionized the treatment of this disease, but concerns about the increased risk for elevated IOP with these agents continue to trouble ophthalmologists.

Accuracy of IOL power prediction using ray tracing is improving and approaching the performance of traditional regression formulae

Oraya Therapeutics Inc. completed enrollment of its INTREPID (I-Ray plus aNti-VEGF TREatment for Patients wIth Wet AMD) clinical trial April 15 in Europe, with 226 subjects.

The American Society of Ophthalmic Administrators (ASOA) has formed an affinity relationship with EyeCanHear LLC of Tampa, FL. EyeCanHear offers eye-care professionals tools to allow their practices to offer hearing-related services for patients.

Why would adults who have moderate to severe visual impairment not seek eye care? Cost or lack of insurance, and perception of no need, are the most common reasons, according to an analysis of data conducted by the Centers for Disease Control and Prevention (CDC).

Alimera Sciences Inc. resubmitted its new drug application, or NDA, for an investigational intravitreal insert containing fluocinolone acetonide (Iluvien) to the FDA May 12.

SynergEyes Inc. has added a new patient-focused video about astigmatism to two proprietary video libraries for eye-care professionals (3D-Eye Office and LUMA, Eyemaginations).

Re-profiling company iCo Therapeutics Inc. has entered into a consulting agreement with independent ophthalmic product development firm Ora Inc. in relation to the phase II clinical development of iCo-007.

Bausch + Lomb (B+L) and the Lions Clubs International Foundation have given $150,000 to Tianjin Eye Hospital in China to finance a specialized pediatric cataract training initiative that will include training and education, equipment, and screenings.

The Wills Eye Institute and Thomas Jefferson University have created the Wills Vision Research Center at Jefferson.

Unilens Vision Inc., which develops, licenses, manufactures, distributes and markets specialty contact lenses, has joined the VisionWeb network of suppliers. This strategic partnership gives independent eye care professionals the ability to browse, place, and track C-Vue disposable contact lens orders from Unilens Vision online through the VisionWeb portal.

May 27, the Friday before Memorial Day, has been designated as ?Don't Fry Day? by the National Council on Skin Cancer Prevention. Prevent Blindness America (PBA) and The Vision Council are voicing their support for the day, as part of Ultraviolet Awareness Month in May.

Contact lens wearers are significantly non-compliant in virtually all the active steps involved in soft contact lens wear, including hand washing, case hygiene, lens disinfection and following the recommended lens replacement schedule, according two online surveys sponsored by the Vistakon Division of Johnson & Johnson Vision Care, Inc.

Scientists from Schepens Eye Research Institute reported that they have regenerated large areas of damaged retinas in mice using induced pluripotent stem cells (IPSCs) derived from skin. The results of their study were published this month in the online science publication PLoS ONE.

WaveTec Vision has secured $15.9 million in Series D financing from existing and new investors.

Vision-Ease Lens (VEL), a designer, manufacturer, and distributor of ophthalmic lenses, is purchasing a cast resin factory in Bangkok, Thailand, from Indelor Lens Co. Ltd. (INDO). The companies expect to finalized the transaction in June after governmental approvals and other conditions to closing are satisfied.

Maui Jim is making a $10,000 contribution to The Ocean Project, a network of more than 1,300 zoos, aquariums, and museums focused on ocean education and conservation, as part of its newest Facebook promotion, "Send a Lei."

Two new brochures from Transitions Optical Inc. provide information and statistics on the types of eye and overall health issues common among older and younger populations. Consumers are encouraged to schedule regular eye exams and ask about eyewear options to enhance and protect their vision.

Fashion Optical Displays has been sold to three of its veteran executives.

Ultraviolet (UV) Awareness Month is May, and the Vision Council (VC) and Prevent Blindness America (PBA) are joining forces to encourage your patients to protect their eyes from UV radiation.

Allergan Inc. and Molecular Partners AG have entered into a license agreement for a phase II proprietary therapeutic protein being investigated as a possible treatment for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME)..